Integration of CTA in the Diagnostic Workup of New Onset Chest Pain in Clinical Practice.

Nazario CarrabbaMartina BerteottiGiulia TaborchiFrancesca CiattiManlio AcquafrescaMario MoroniAngela MiglioriniVittorio MieleNiccolò MarchionniRenato Valenti

Published in: BioMed research international (2019)

In clinical practice, CTA, as a first- or second-line investigation, most commonly detected no O-CAD in new onset chest pain patients, leading us to safely avoid unnecessary ICA or additional functional tests. The use of CTA as a first-line investigation also appears to be cost saving, but its cost-effectiveness remains to be demonstrated in larger studies.

Keyphrases

clinical practice
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
coronary artery disease
prognostic factors
peritoneal dialysis
case control